Cancer and Pharmacology

Treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients. Research in discovering and designing drugs with new chemistry structure or mechanism of action is critical to overcome the drug resistance problem and give patient better chance to survive longer. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to specifically bind to specific cells or proteins. Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.The clinical toxicology importance of any drug interaction depends on factors that are drug-patient and administration related. Generally, a doubling or more in plasma drug concentration has the potential for enhanced adverse or beneficial drug response Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticancer agents. Interactions with other medications can cause small changes in the pharmacokinetics or pharmacodynamics of a chemotherapy agent that could significantly alter its efficacy or toxicity.

  • Therapeutic antibodies
  • Functional genomics
  • Novel drug delivery system
  • Cancer drug designing
  • Nanotechnology and nanomedicine
  • Pharmacodynamics and pharmacokinetics
  • Regulatory issues in cancer research

Related Conference of Cancer and Pharmacology

April 24-25, 2017

16th Global Annual Oncologists Meeting

Dubai, UAE
May 25-27, 2017

Global Summit on Oncology & Cancer

Osaka, Japan
September 18-19, 2017

International Conference on Cancer Biology R&D and Market

Philadelphia, Pennsylvania, USA
June 29-July 01, 2017

International Conference on Hematology and Oncology

Bangkok, Thailand
July 17-19, 2017

19th Euro Congress on Cancer Science and Therapy

Lisbon, Portugal
July 20-21, 2017

3rd Annual Conference on Gynecologic Oncology

Chicago, Illinois, USA
July 20-21, 2017

World Congress on Preventive Oncology

Chicago, Illinois, USA
August 24-25, 2017

9thWorld Biomarkers Congress

Birmingham, UK
August 28-30, 2017

Oncologist & Diagnostics Conference

Brussels, Belgium
October 23-25, 2017

World Cancer Meeting

Seoul , South Korea
October 9-10, 2017

Global Meeting on Molecular & Cancer Biomarkers

Dubai, UAE
October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
October 19-20, 2017

15th World Oncologists Annual Conference

New York ,USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

Frankfurt, Germany
November 09-10, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE

Cancer and Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in